← Open Payments lookup

SHAKIRAT ODUKALE: Open Payments

NPI 1699337592 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,840 in 96 payments from 11 companies in 2025. Trend: 2023 $2,224 · 2024 $1,693 · 2025 $1,840

Food & beverage: $1,728Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.18$346
ABBVIE INC.31$338
Neurocrine BioSciences, Inc.9$288
E.R. Squibb & Sons, L.L.C.10$285
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$272
Janssen Pharmaceuticals, Inc6$109
Alkermes, Inc.5$84
Otsuka America Pharmaceutical, Inc.4$71
Braeburn Inc.1$17
Lundbeck LLC1$15

Products named: VRAYLAR, INGREZZA, COBENFY, CAPLYTA, AUSTEDO XR, UZEDY, ARISTADA, INVEGA SUSTENNA.

Industry payments across NJ — which companies pay providers there.